Keywords: Neurodegeneration, Neurodegeneration, clinical uncertain Parkinsonism, NM-MRIBrain dopamine transporter SPECT imaging is routinely used to assess striatal dopaminergic deficit in the differentiation of essential tremor from degenerative parkinsonism in clinically uncertain parkinsonism (CUP). Neuromelanin (NM)-MRI detects nigral depigmentation with good diagnostic accuracy in confirmed Parkinson’s Disease; but its diagnostic value in CUP is unclear. Using voxel-based analysis following optimised automatic registration, we investigated the topography of NM loss in CUP, and show that voxels that best discriminate between non-neurodegenerative and neurodegenerative CUP are co-located in the dorsolateral substantia nigra.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords